Click here to get full coverage on Lyka Labs Ltd is Rated Strong Sell - Markets Mojo

Lyka Labs Ltd is Rated Strong Sell  Markets Mojo

Lyka Labs Ltd is Rated Strong Sell - Markets Mojo

Click here to get full coverage on Lyka Labs Consolidated March 2026 Net Sales at Rs 28.03 crore, down 16.15% Y-o-Y - Moneycontrol.com

Lyka Labs Consolidated March 2026 Net Sales at Rs 28.03 crore, down 16.15% Y-o-Y  Moneycontrol.com

Lyka Labs Consolidated March 2026 Net Sales at Rs 28.03 crore, down 16.15% Y-o-Y - Moneycontrol.com

Click here to get full coverage on Are Lyka Labs Limited's (NSE:LYKALABS) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - simplywall.st

Are Lyka Labs Limited's (NSE:LYKALABS) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?  simplywall.st

Are Lyka Labs Limited's (NSE:LYKALABS) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - simplywall.st

Click here to get full coverage on Lyka Labs reports consolidated net loss of Rs 7.61 crore in the March 2026 quarter - Business Standard

Lyka Labs reports consolidated net loss of Rs 7.61 crore in the March 2026 quarter  Business Standard

Lyka Labs reports consolidated net loss of Rs 7.61 crore in the March 2026 quarter - Business Standard

Click here to get full coverage on Lyka Labs posts FY26 net loss of ₹322.88 crore - scanx.trade

Lyka Labs posts FY26 net loss of ₹322.88 crore  scanx.trade

Lyka Labs posts FY26 net loss of ₹322.88 crore - scanx.trade

Click here to get full coverage on “Not Filed To Harass Or Embarrass”: NCLAT Sets Aside Rejection Of Lyka Labs' CIRP Plea Against Modi... - LiveLawBiz

“Not Filed To Harass Or Embarrass”: NCLAT Sets Aside Rejection Of Lyka Labs' CIRP Plea Against Modi...  LiveLawBiz

“Not Filed To Harass Or Embarrass”: NCLAT Sets Aside Rejection Of Lyka Labs' CIRP Plea Against Modi... - LiveLawBiz

Click here to get full coverage on Stocks to Watch, May 20: SPARC, Omaxe, Mastek, JSW Energy, Jindal, ITC, Lyka Labs, Airfloa Rail - BusinessLine

Stocks to Watch, May 20: SPARC, Omaxe, Mastek, JSW Energy, Jindal, ITC, Lyka Labs, Airfloa Rail  BusinessLine

Stocks to Watch, May 20: SPARC, Omaxe, Mastek, JSW Energy, Jindal, ITC, Lyka Labs, Airfloa Rail - BusinessLine

Click here to get full coverage on NCLAT allows Lyka Labs appeal; asks Modi Lifecare to pay Rs 63 lakh or face insolvency proceedings - The Economic Times

NCLAT allows Lyka Labs appeal; asks Modi Lifecare to pay Rs 63 lakh or face insolvency proceedings  The Economic Times

NCLAT allows Lyka Labs appeal; asks Modi Lifecare to pay Rs 63 lakh or face insolvency proceedings - The Economic Times

Click here to get full coverage on Lyka Labs Standalone March 2026 Net Sales at Rs 28.03 crore, down 8.15% Y-o-Y - Moneycontrol.com

Lyka Labs Standalone March 2026 Net Sales at Rs 28.03 crore, down 8.15% Y-o-Y  Moneycontrol.com

Lyka Labs Standalone March 2026 Net Sales at Rs 28.03 crore, down 8.15% Y-o-Y - Moneycontrol.com

Click here to get full coverage on Lyka Labs Q4 FY26: Steep Losses Amid Operational Crisis Signal Deepening Distress - Markets Mojo

Lyka Labs Q4 FY26: Steep Losses Amid Operational Crisis Signal Deepening Distress  Markets Mojo

Lyka Labs Q4 FY26: Steep Losses Amid Operational Crisis Signal Deepening Distress - Markets Mojo

Click here to get full coverage on Lyka Labs Limited Schedules Board Meeting on May 25, 2026 to Approve Q4 and FY26 Financial Results - scanx.trade

Lyka Labs Limited Schedules Board Meeting on May 25, 2026 to Approve Q4 and FY26 Financial Results  scanx.trade

Lyka Labs Limited Schedules Board Meeting on May 25, 2026 to Approve Q4 and FY26 Financial Results - scanx.trade

Click here to get full coverage on Lyka Labs reports consolidated nil net profit/loss in the December 2025 quarter - Business Standard

Lyka Labs reports consolidated nil net profit/loss in the December 2025 quarter  Business Standard

Lyka Labs reports consolidated nil net profit/loss in the December 2025 quarter - Business Standard

Click here to get full coverage on Lyka Labs Limited Schedules Board Meeting on March 31, 2026 for Cost Accountant Appointment - scanx.trade

Lyka Labs Limited Schedules Board Meeting on March 31, 2026 for Cost Accountant Appointment  scanx.trade

Lyka Labs Limited Schedules Board Meeting on March 31, 2026 for Cost Accountant Appointment - scanx.trade

Click here to get full coverage on Markets Rally, But Lyka Labs Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off - Markets Mojo

Markets Rally, But Lyka Labs Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off  Markets Mojo

Markets Rally, But Lyka Labs Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off - Markets Mojo

Click here to get full coverage on Lyka Labs Clarifies No Material Events Behind Recent Share Price Movement - scanx.trade

Lyka Labs Clarifies No Material Events Behind Recent Share Price Movement  scanx.trade

Lyka Labs Clarifies No Material Events Behind Recent Share Price Movement - scanx.trade

Click here to get full coverage on Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.54 Amid Continued Downtrend - Markets Mojo

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.54 Amid Continued Downtrend  Markets Mojo

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.54 Amid Continued Downtrend - Markets Mojo

Click here to get full coverage on Lyka Labs Reports Net Loss of Rs 362.68 Lakhs in Q2 FY26 - scanx.trade

Lyka Labs Reports Net Loss of Rs 362.68 Lakhs in Q2 FY26  scanx.trade

Lyka Labs Reports Net Loss of Rs 362.68 Lakhs in Q2 FY26 - scanx.trade

Click here to get full coverage on NCLT Reserves Order on Lyka Labs Amalgamation Case After Income Tax Department Clearance - scanx.trade

NCLT Reserves Order on Lyka Labs Amalgamation Case After Income Tax Department Clearance  scanx.trade

NCLT Reserves Order on Lyka Labs Amalgamation Case After Income Tax Department Clearance - scanx.trade

Click here to get full coverage on NCLT Approves Lyka Labs' Scheme of Amalgamation with Lyka Exports Limited - scanx.trade

NCLT Approves Lyka Labs' Scheme of Amalgamation with Lyka Exports Limited  scanx.trade

NCLT Approves Lyka Labs' Scheme of Amalgamation with Lyka Exports Limited - scanx.trade

Click here to get full coverage on NCLT Reserves Order on Lyka Labs-Lyka Exports Merger, Signals No Objection - scanx.trade

NCLT Reserves Order on Lyka Labs-Lyka Exports Merger, Signals No Objection  scanx.trade

NCLT Reserves Order on Lyka Labs-Lyka Exports Merger, Signals No Objection - scanx.trade

Click here to get full coverage on Lyka Labs Q3FY26 Results: Revenue Declines 6.6% YoY to ₹3,072.79 Lakhs - scanx.trade

Lyka Labs Q3FY26 Results: Revenue Declines 6.6% YoY to ₹3,072.79 Lakhs  scanx.trade

Lyka Labs Q3FY26 Results: Revenue Declines 6.6% YoY to ₹3,072.79 Lakhs - scanx.trade

Click here to get full coverage on Lyka Labs Amalgamation Scheme with Lyka Exports Becomes Effective from April 8, 2026 - scanx.trade

Lyka Labs Amalgamation Scheme with Lyka Exports Becomes Effective from April 8, 2026  scanx.trade

Lyka Labs Amalgamation Scheme with Lyka Exports Becomes Effective from April 8, 2026 - scanx.trade

Click here to get full coverage on Our Take On Lyka Labs Limited’s (NSE:LYKALABS) CEO Salary - Yahoo Finance

Our Take On Lyka Labs Limited’s (NSE:LYKALABS) CEO Salary  Yahoo Finance

Our Take On Lyka Labs Limited’s (NSE:LYKALABS) CEO Salary - Yahoo Finance

Click here to get full coverage on Is Lyka Labs (NSE:LYKALABS) Using Debt In A Risky Way? - Yahoo Finance

Is Lyka Labs (NSE:LYKALABS) Using Debt In A Risky Way?  Yahoo Finance

Is Lyka Labs (NSE:LYKALABS) Using Debt In A Risky Way? - Yahoo Finance

Click here to get full coverage on Lyka Labs Ltd Valuation Shifts Signal Heightened Risk Amidst Market Underperformance - Markets Mojo

Lyka Labs Ltd Valuation Shifts Signal Heightened Risk Amidst Market Underperformance  Markets Mojo

Lyka Labs Ltd Valuation Shifts Signal Heightened Risk Amidst Market Underperformance - Markets Mojo

Click here to get full coverage on Lyka Labs Cost Auditors Resign for Financial Year 2025-26 - scanx.trade

Lyka Labs Cost Auditors Resign for Financial Year 2025-26  scanx.trade

Lyka Labs Cost Auditors Resign for Financial Year 2025-26 - scanx.trade

Click here to get full coverage on LYKALABS Stock Price and Chart — NSE:LYKALABS - TradingView

LYKALABS Stock Price and Chart — NSE:LYKALABS  TradingView

LYKALABS Stock Price and Chart — NSE:LYKALABS - TradingView

Click here to get full coverage on NCLAT Clarifies Invoice Requirements in Section 9 IBC Petitions — Lyka Labs v. Modi Lifecare - IndiaLaw LLP

NCLAT Clarifies Invoice Requirements in Section 9 IBC Petitions — Lyka Labs v. Modi Lifecare  IndiaLaw LLP

NCLAT Clarifies Invoice Requirements in Section 9 IBC Petitions — Lyka Labs v. Modi Lifecare - IndiaLaw LLP

Click here to get full coverage on Lyka Labs secures Indian patent for Pregabalin Gel 8% - Indian Pharma Post

Lyka Labs secures Indian patent for Pregabalin Gel 8%  Indian Pharma Post

Lyka Labs secures Indian patent for Pregabalin Gel 8% - Indian Pharma Post

Click here to get full coverage on Lyka Labs gets Indian Patent for diabetic neuropathic pain management gel Pregabalin - Medical Dialogues

Lyka Labs gets Indian Patent for diabetic neuropathic pain management gel Pregabalin  Medical Dialogues

Lyka Labs gets Indian Patent for diabetic neuropathic pain management gel Pregabalin - Medical Dialogues

Click here to get full coverage on Ipca Labs approves acquisition of 26.5% stake in Lyka Labs - Mint

Ipca Labs approves acquisition of 26.5% stake in Lyka Labs  Mint

Ipca Labs approves acquisition of 26.5% stake in Lyka Labs - Mint

Click here to get full coverage on Lyka Labs Gets CDSCO Panel Nod To Manufacture, Market Atopic Dermatitis Drug - Medical Dialogues

Lyka Labs Gets CDSCO Panel Nod To Manufacture, Market Atopic Dermatitis Drug  Medical Dialogues

Lyka Labs Gets CDSCO Panel Nod To Manufacture, Market Atopic Dermatitis Drug - Medical Dialogues

Click here to get full coverage on Lyka Labs shares rally 7% on CDSCO nod for diabetic neuropathy pain drug - Business Standard

Lyka Labs shares rally 7% on CDSCO nod for diabetic neuropathy pain drug  Business Standard

Lyka Labs shares rally 7% on CDSCO nod for diabetic neuropathy pain drug - Business Standard

Click here to get full coverage on Lyka Labs Q2FY22 consolidated PAT at Rs. 28.43Cr - Indian Pharma Post

Lyka Labs Q2FY22 consolidated PAT at Rs. 28.43Cr  Indian Pharma Post

Lyka Labs Q2FY22 consolidated PAT at Rs. 28.43Cr - Indian Pharma Post

Click here to get full coverage on Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer - Indian Pharma Post

Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer  Indian Pharma Post

Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer - Indian Pharma Post

Click here to get full coverage on Ipca Laboratories hikes stake in Lyka Labs - Business Standard

Ipca Laboratories hikes stake in Lyka Labs  Business Standard

Ipca Laboratories hikes stake in Lyka Labs - Business Standard

Click here to get full coverage on SAT lifts bar on Lyka Labs from accessing capital markets - Moneycontrol.com

SAT lifts bar on Lyka Labs from accessing capital markets  Moneycontrol.com

SAT lifts bar on Lyka Labs from accessing capital markets - Moneycontrol.com

Click here to get full coverage on Lyka Labs Ltd. Share Price Today | Lyka Labs Live NSE/BSE - Value Research

Lyka Labs Ltd. Share Price Today | Lyka Labs Live NSE/BSE  Value Research

Lyka Labs Ltd. Share Price Today | Lyka Labs Live NSE/BSE - Value Research

Click here to get full coverage on Promoters of Lyka Labs settle case with Sebi; pays Rs 3.07 lakh as settlements charges - ETLegalWorld.com

Promoters of Lyka Labs settle case with Sebi; pays Rs 3.07 lakh as settlements charges  ETLegalWorld.com

Promoters of Lyka Labs settle case with Sebi; pays Rs 3.07 lakh as settlements charges - ETLegalWorld.com

Click here to get full coverage on Ipca Labs' board approves acquisition of over 26% stake in Lyka Labs - Business Standard

Ipca Labs' board approves acquisition of over 26% stake in Lyka Labs  Business Standard

Ipca Labs' board approves acquisition of over 26% stake in Lyka Labs - Business Standard

Click here to get full coverage on SEBI bans Lyka Labs for 3 years for manipulating GDR to raise Rs 37 crore - Medical Dialogues

SEBI bans Lyka Labs for 3 years for manipulating GDR to raise Rs 37 crore  Medical Dialogues

SEBI bans Lyka Labs for 3 years for manipulating GDR to raise Rs 37 crore - Medical Dialogues

Click here to get full coverage on Lyka Labs acquisition by Ipca Laboratories could open strong growth opportunities - Moneycontrol.com

Lyka Labs acquisition by Ipca Laboratories could open strong growth opportunities  Moneycontrol.com

Lyka Labs acquisition by Ipca Laboratories could open strong growth opportunities - Moneycontrol.com

Click here to get full coverage on LYKA LABS LTD Share Price Today - Live LYKALABS Stock Price for NSE/BSE - Upstox

LYKA LABS LTD Share Price Today - Live LYKALABS Stock Price for NSE/BSE  Upstox

LYKA LABS LTD Share Price Today - Live LYKALABS Stock Price for NSE/BSE - Upstox

Click here to get full coverage on Lyka Labs inks out-licensing deal with US-based generics firm - Business Standard

Lyka Labs inks out-licensing deal with US-based generics firm  Business Standard

Lyka Labs inks out-licensing deal with US-based generics firm - Business Standard

Click here to get full coverage on Lyka Labs sells Tarapur manufacturing unit for Rs 38.6 crore - The Economic Times

Lyka Labs sells Tarapur manufacturing unit for Rs 38.6 crore  The Economic Times

Lyka Labs sells Tarapur manufacturing unit for Rs 38.6 crore - The Economic Times

Click here to get full coverage on Lyka Labs Hit 52-Week High After Ipca Buys Shares Via Bulk Deals - Goodreturns

Lyka Labs Hit 52-Week High After Ipca Buys Shares Via Bulk Deals  Goodreturns

Lyka Labs Hit 52-Week High After Ipca Buys Shares Via Bulk Deals - Goodreturns

Click here to get full coverage on Hetero buys Lyka JV pie - Business Standard

Hetero buys Lyka JV pie  Business Standard

Hetero buys Lyka JV pie - Business Standard

Click here to get full coverage on Serum`s Poonawala buys stake in Lyka Labs - Business Standard

Serum`s Poonawala buys stake in Lyka Labs  Business Standard

Serum`s Poonawala buys stake in Lyka Labs - Business Standard

Click here to get full coverage on Why Is Lyka Labs Limited (LYKALABS.BO) Stock Down Today? - Meyka

Why Is Lyka Labs Limited (LYKALABS.BO) Stock Down Today?  Meyka

Why Is Lyka Labs Limited (LYKALABS.BO) Stock Down Today? - Meyka

Click here to get full coverage on NCLAT allows Lyka Labs appeal; asks Modi Lifecare to pay Rs 63 lakh or face insolvency proceedings - MSN

NCLAT allows Lyka Labs appeal; asks Modi Lifecare to pay Rs 63 lakh or face insolvency proceedings  MSN

NCLAT allows Lyka Labs appeal; asks Modi Lifecare to pay Rs 63 lakh or face insolvency proceedings - MSN

Click here to get full coverage on Lyka Labs Ltd Locks at Lower Circuit With 4.69% Loss — Sellers Queue, No Buyers in Sight - Markets Mojo

Lyka Labs Ltd Locks at Lower Circuit With 4.69% Loss — Sellers Queue, No Buyers in Sight  Markets Mojo

Lyka Labs Ltd Locks at Lower Circuit With 4.69% Loss — Sellers Queue, No Buyers in Sight - Markets Mojo

Click here to get full coverage on Lyka Labs Ltd Locks at Lower Circuit With 4.65% Loss — Sellers Queue, No Buyers in Sight - Markets Mojo

Lyka Labs Ltd Locks at Lower Circuit With 4.65% Loss — Sellers Queue, No Buyers in Sight  Markets Mojo

Lyka Labs Ltd Locks at Lower Circuit With 4.65% Loss — Sellers Queue, No Buyers in Sight - Markets Mojo

Click here to get full coverage on Lyka Labs Ltd Locks at Upper Circuit With 4.95% Gain — Buyers Queue, Sellers Absent - Markets Mojo

Lyka Labs Ltd Locks at Upper Circuit With 4.95% Gain — Buyers Queue, Sellers Absent  Markets Mojo

Lyka Labs Ltd Locks at Upper Circuit With 4.95% Gain — Buyers Queue, Sellers Absent - Markets Mojo

Click here to get full coverage on Lyka Labs Ltd Locks at Upper Circuit With 4.92% Gain — Buyers Queue, Sellers Absent - Markets Mojo

Lyka Labs Ltd Locks at Upper Circuit With 4.92% Gain — Buyers Queue, Sellers Absent  Markets Mojo

Lyka Labs Ltd Locks at Upper Circuit With 4.92% Gain — Buyers Queue, Sellers Absent - Markets Mojo

Click here to get full coverage on Five Consecutive Losses Push Lyka Labs Ltd to a New 52-Week Low - Markets Mojo

Five Consecutive Losses Push Lyka Labs Ltd to a New 52-Week Low  Markets Mojo

Five Consecutive Losses Push Lyka Labs Ltd to a New 52-Week Low - Markets Mojo

Click here to get full coverage on Lyka Labs Ltd Stock Hits 52-Week Low Amidst Continued Downtrend - Markets Mojo

Lyka Labs Ltd Stock Hits 52-Week Low Amidst Continued Downtrend  Markets Mojo

Lyka Labs Ltd Stock Hits 52-Week Low Amidst Continued Downtrend - Markets Mojo

Click here to get full coverage on Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.56 Amid Continued Downtrend - Markets Mojo

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.56 Amid Continued Downtrend  Markets Mojo

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.56 Amid Continued Downtrend - Markets Mojo

Click here to get full coverage on Lyka Labs Ltd Stock Falls to 52-Week Low of Rs 55 Amidst Continued Downtrend - Markets Mojo

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs 55 Amidst Continued Downtrend  Markets Mojo

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs 55 Amidst Continued Downtrend - Markets Mojo

Click here to get full coverage on Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.70 Amidst Continued Downtrend - Markets Mojo

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.70 Amidst Continued Downtrend  Markets Mojo

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.70 Amidst Continued Downtrend - Markets Mojo

Click here to get full coverage on Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.60 Amidst Continued Underperformance - Markets Mojo

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.60 Amidst Continued Underperformance  Markets Mojo

Lyka Labs Ltd Stock Falls to 52-Week Low of Rs.60 Amidst Continued Underperformance - Markets Mojo

Click here to get full coverage on IPCA Laboratories Ltd to acquire majority stake in Lyka Labs Ltd - EquityBulls

IPCA Laboratories Ltd to acquire majority stake in Lyka Labs Ltd  EquityBulls

IPCA Laboratories Ltd to acquire majority stake in Lyka Labs Ltd - EquityBulls

Click here to get full coverage on Lyka Labs shares hit new 52-week high after Ipca Laboratories acquires 48 lakh shares of the company - Zee Business

Lyka Labs shares hit new 52-week high after Ipca Laboratories acquires 48 lakh shares of the company  Zee Business

LYKALABS

Price Chart

Key Statistics

Technicals

About LYKALABS

Latest News

Lyka Labs Ltd is Rated Strong Sell - Markets Mojo

Lyka Labs Consolidated March 2026 Net Sales at Rs 28.03 crore, down 16.15% Y-o-Y - Moneycontrol.com

Are Lyka Labs Limited's (NSE:LYKALABS) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - simplywall.st

Advanced Charts

Top Gainers

Top Losers